Skip to main content

Biopharma Startups

Updated November 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
915
Total Funding
$896.9M
Avg Funding
$35.9M
Global Reach
7
countries

Top Cities for Biopharma

Copenhagen
Franklin
Chicago
Montréal
Lausanne
Oxford

Recently Funded Companies

Export
Copenhagen, Denmark

Henlez provides biologic solutions to manage recurrent and follicular skin disorders.

$988K raised
Oct 2022

Founder Contacts

41,000+ verified contacts

Franklin, United States

CASS Pharmaceuticals is a medical company that provides rapid-acting insulin for diabetic patients.

$2.0M raised
Oct 2022

Founder Contacts

41,000+ verified contacts

Chicago, United States

Xentria is a biotech company focused on developing novel therapeutics to address unmet clinical needs.

$25.0M raised
Oct 2022

Founder Contacts

41,000+ verified contacts

Montréal, Canada

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

$69.3M raised
Oct 2022

Founder Contacts

41,000+ verified contacts

Lausanne, Switzerland

ArcoScreen is a Swiss medtech is developing a new microfluidic discovery platform for drug screening targeting cell membrane receptors.

$100K raised
Oct 2022

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

$30.0M raised
Oct 2022

Founder Contacts

41,000+ verified contacts

North Chicago, United States

Covira Surgical engages in the development of drugs that modulate the biological activity of the gut microbiome's resident bacteria.

$9.1M raised
Oct 2022

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

Bloomsbury Genetic Therapies develops curative treatments for rare neurological and metabolic diseases using gene therapy technologies.

$5.6M raised
Oct 2022

Founder Contacts

41,000+ verified contacts

Nijmegen, The Netherlands

Protinhi Therapeutics is a preclinical stage biotech company developing antivirals against viral threats.

$2.5M raised
Oct 2022

Founder Contacts

41,000+ verified contacts

Castroville, United States

Biopharmaceutical Research Company develops active pharmaceutical ingredients for plant therapeutics.

$20.0M raised
Oct 2022

Founder Contacts

41,000+ verified contacts

Minneapolis, United States

Vergent Bioscience is a biotech company focusing on the development of tumor-targeted molecular imaging molecules for cancer surgery.

$21.5M raised
Oct 2022

Founder Contacts

41,000+ verified contacts

Chicago, United States

ClostraBio is a biopharma company developing therapeutics for food allergies.

$4.0M raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Redwood City, United States

Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.

$150.0M raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Morgantown, United States

ICaPath is a biotech startup that engages in nanoparticle immunotherapy and immunodiagnostics.

$650K raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Vancouver, Canada

EGF Theramed Health is a consumer technology company engaged in the provision of biomedical online services.

$10.0M raised
Sep 2022

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.

$43.5M raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Los Angeles, United States

ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.

$300.0M raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Indianapolis, United States

Point Biopharma focused on the development and commercialization of radioligand therapies for the treatment of cancer.

$125.0M raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Houston, United States

Systemic Bio creates bioprinted organs-on-chips for drug discovery and development.

$15.0M raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Melbourne, Australia

OccuRx is a biopharmaceutical company that focuses on the development of innovative therapeutic strategies.

$14.5M raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Wageningen, The Netherlands

Upstream Foods is developing a novel fat ingredient to uplevel seafood alternatives

$495K raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Scottsdale, United States

Sonoran Biosciences is an early stage pharmaceutical company that has developed SB Gel, the first viscous sustained release carrier.

$260K raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Menlo Park, United States

3T Biosciences is an immunotherapy company that develops next-generation therapies for cancer and immune-mediated diseases.

$40.0M raised
Aug 2022

Founder Contacts

41,000+ verified contacts

Carlsbad, United States

Cisterna Biologics is a technology company that aims to solve the biotech industry's main challenges in developing mRNA-based therapeutics

$500K raised
Aug 2022

Founder Contacts

41,000+ verified contacts

Tarrytown, United States

Visiox biopharmaceutical company focused on the development and commercialization to address highly prevalent diseases.

$7.0M raised
Aug 2022

Founder Contacts

41,000+ verified contacts

Showing 776 to 800 of 915 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.

Average Funding
$35.9M
Total Funding Tracked
$896.9M
Countries Represented
7

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Chicago
2 companies$29.0M
2.Copenhagen
1 companies$988K
3.Franklin
1 companies$2.0M
4.Montréal
1 companies$69.3M
5.Lausanne
1 companies$100K

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked